-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Protagonist Therapeutics, Inc annual/quarterly Depreciation history and growth rate from Q1 2021 to Q1 2022.
- Protagonist Therapeutics, Inc Depreciation for the quarter ending March 31, 2022 was $249K, a 38.3% increase year-over-year.
- Protagonist Therapeutics, Inc annual Depreciation for 2023 was $977K, a 5.33% decline from 2022.
- Protagonist Therapeutics, Inc annual Depreciation for 2022 was $1.03M, a 26.9% increase from 2021.
- Protagonist Therapeutics, Inc annual Depreciation for 2021 was $813K, a 3.04% increase from 2020.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)